Schedule 13G ownership disclosure

Precigen Inc

Common Stock · CUSIP: 74017N105

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Patient Capital Management, LLC

    Shares: 45,223,463.00 · Class: 13.6%

  • Patient Opportunity Trust, a Series of Advisor Managed Portfolios

    Shares: 35,786,370.00 · Class: 11%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-005965
Form type
SCHEDULE 13G/A
Filer
PRECIGEN, INC.
CIK
CIK 1356090
Filed
Oct 30, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub